跳至主要内容
临床试验/NCT00473915
NCT00473915已完成4 期

Intranasal Steroids Prevent Antigen-Induced Hyperresponsiveness of the Nasal Ocular Response

University of Chicago2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2007年4月1日最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
20
试验地点
2
主要终点
Change in ocular symptoms

研究概览

简要总结

Eye symptoms of tearing, redness and itch frequently occur in patients with allergic rhinitis or hayfever. The purpose of this study is to learn whether placing allergen (the substance that causes allergies) in the nose several days in a row will cause an increase in eye symptoms and whether receiving a nasal steroid spray will prevent these eye symptoms.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Males and females between 18 and 45 years of age.
  • History of grass and/or ragweed allergic rhinitis.
  • Positive skin test to grass and/or ragweed antigen.
  • Positive response to screening nasal challenge.

排除标准

  • Physical signs or symptoms suggestive of renal, hepatic or cardiovascular disease.
  • Pregnant or lactating women.
  • Upper respiratory infection within 14 days of study start.

结局指标

主要结局

Change in ocular symptoms

时间窗: between days 1 and 3

次要结局

  • number of eosinophils(between days 1 and 3)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Robert Naclerio

Professor

University of Chicago

研究点 (2)

Loading locations...

相似试验